Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 78

Similar articles for PubMed (Select 24074577)

1.

Differential potential for envelope glycoprotein-mediated steric shielding of host cell surface proteins among filoviruses.

Noyori O, Matsuno K, Kajihara M, Nakayama E, Igarashi M, Kuroda M, Isoda N, Yoshida R, Takada A.

Virology. 2013 Nov;446(1-2):152-61. doi: 10.1016/j.virol.2013.07.029. Epub 2013 Aug 28.

2.

Chemical and Structural Aspects of Ebola Virus Entry Inhibitors.

Nyakatura EK, Frei JC, Lai JR.

ACS Infect Dis. 2015 Jan 9;1(1):42-52. Epub 2014 Dec 11. Review.

3.

Interaction between TIM-1 and NPC1 Is Important for Cellular Entry of Ebola Virus.

Kuroda M, Fujikura D, Nanbo A, Marzi A, Noyori O, Kajihara M, Maruyama J, Matsuno K, Miyamoto H, Yoshida R, Feldmann H, Takada A.

J Virol. 2015 Jun 15;89(12):6481-93. doi: 10.1128/JVI.03156-14. Epub 2015 Apr 8.

PMID:
25855742
4.

Characterizing alpha helical properties of Ebola viral proteins as potential targets for inhibition of alpha-helix mediated protein-protein interactions.

Chakraborty S, Rao BJ, Asgeirsson B, Dandekar A.

Version 3. F1000Res. 2014 Oct 24 [revised 2015 Jan 27];3:251. doi: 10.12688/f1000research.5573.3. eCollection 2014.

5.

Size dependence of steric shielding and multivalency effects for globular binding inhibitors.

Vonnemann J, Liese S, Kuehne C, Ludwig K, Dernedde J, Böttcher C, Netz RR, Haag R.

J Am Chem Soc. 2015 Feb 25;137(7):2572-9. doi: 10.1021/ja5114084. Epub 2015 Feb 12.

PMID:
25623606
6.

Suppression of Fas-mediated apoptosis via steric shielding by filovirus glycoproteins.

Noyori O, Nakayama E, Maruyama J, Yoshida R, Takada A.

Biochem Biophys Res Commun. 2013 Nov 29;441(4):994-8. doi: 10.1016/j.bbrc.2013.11.018. Epub 2013 Nov 12.

PMID:
24239546
7.

Characterization of the envelope glycoprotein of a novel filovirus, lloviu virus.

Maruyama J, Miyamoto H, Kajihara M, Ogawa H, Maeda K, Sakoda Y, Yoshida R, Takada A.

J Virol. 2014 Jan;88(1):99-109. doi: 10.1128/JVI.02265-13. Epub 2013 Oct 16.

8.

[Research progress on ebola virus glycoprotein].

Ding GY, Wang ZY, Gao L, Jiang BF.

Bing Du Xue Bao. 2013 Mar;29(2):233-7. Review. Chinese.

PMID:
23757858
9.

Endocytic pathways involved in filovirus entry: advances, implications and future directions.

Bhattacharyya S, Mulherkar N, Chandran K.

Viruses. 2012 Dec;4(12):3647-64. Review.

10.

Host cell factors in filovirus entry: novel players, new insights.

Hofmann-Winkler H, Kaup F, Pöhlmann S.

Viruses. 2012 Dec;4(12):3336-62. Review.

11.

Filoviruses utilize glycosaminoglycans for their attachment to target cells.

Salvador B, Sexton NR, Carrion R Jr, Nunneley J, Patterson JL, Steffen I, Lu K, Muench MO, Lembo D, Simmons G.

J Virol. 2013 Mar;87(6):3295-304. doi: 10.1128/JVI.01621-12. Epub 2013 Jan 9.

12.

The membrane-proximal region (MPR) of herpes simplex virus gB regulates association of the fusion loops with lipid membranes.

Shelly SS, Cairns TM, Whitbeck JC, Lou H, Krummenacher C, Cohen GH, Eisenberg RJ.

MBio. 2012 Nov 20;3(6). pii: e00429-12. doi: 10.1128/mBio.00429-12.

13.

Filovirus entry into cells - new insights.

Miller EH, Chandran K.

Curr Opin Virol. 2012 Apr;2(2):206-14. doi: 10.1016/j.coviro.2012.02.015. Epub 2012 Mar 23. Review.

14.

Anti-tetherin activities of HIV-1 Vpu and Ebola virus glycoprotein do not involve removal of tetherin from lipid rafts.

Lopez LA, Yang SJ, Exline CM, Rengarajan S, Haworth KG, Cannon PM.

J Virol. 2012 May;86(10):5467-80. doi: 10.1128/JVI.06280-11. Epub 2012 Mar 7.

15.

Filovirus tropism: cellular molecules for viral entry.

Takada A.

Front Microbiol. 2012 Feb 6;3:34. doi: 10.3389/fmicb.2012.00034. eCollection 2012.

16.

Ebola virus glycoprotein needs an additional trigger, beyond proteolytic priming for membrane fusion.

Bale S, Liu T, Li S, Wang Y, Abelson D, Fusco M, Woods VL Jr, Saphire EO.

PLoS Negl Trop Dis. 2011 Nov;5(11):e1395. doi: 10.1371/journal.pntd.0001395. Epub 2011 Nov 15.

17.

Evasion of the interferon-mediated antiviral response by filoviruses.

Cárdenas WB.

Viruses. 2010 Jan;2(1):262-82. doi: 10.3390/v2010262. Epub 2010 Jan 21.

18.

Advances in virus-like particle vaccines for filoviruses.

Warfield KL, Aman MJ.

J Infect Dis. 2011 Nov;204 Suppl 3:S1053-9. doi: 10.1093/infdis/jir346. Review.

19.

Intracellular events and cell fate in filovirus infection.

Olejnik J, Ryabchikova E, Corley RB, Mühlberger E.

Viruses. 2011 Aug;3(8):1501-31. doi: 10.3390/v3081501. Review.

20.

Lethality and pathogenesis of airborne infection with filoviruses in A129 α/β -/- interferon receptor-deficient mice.

Lever MS, Piercy TJ, Steward JA, Eastaugh L, Smither SJ, Taylor C, Salguero FJ, Phillpotts RJ.

J Med Microbiol. 2012 Jan;61(Pt 1):8-15. doi: 10.1099/jmm.0.036210-0. Epub 2011 Aug 18.

PMID:
21852521
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk